UBS ETFIn order to proceed, you must confirm that you are a qualified or institutional investor based in Finland.

The following information does not constitute distribution.

Please note that this webpage gives qualified investors access to the entire UBS ETF product offering. Therefore, some products on this webpage may NOT be authorized, recognised or registered for distribution neither in Finland, nor in your country or as the case may be nor in any other country. No distribution must be carried out for it. No marketing material must be handed out to clients on any occasion. The presentation of marketing material in client halls is strictly forbidden. Reference to these funds in client mailings must not be made. In case that you don't want or are not allowed to see the full ETF range, please do not proceed. Enter this site as Private Investor.

For marketing and information purposes by UBS.

    For professional clients. The information and opinions contained in this document have been compiled or arrived at based upon information obtained from sources believed to be reliable and in good faith, but is not guaranteed as being accurate, nor is it a complete statement or summary of the securities, markets or developments referred to in the document. UBS AG and / or other members of the UBS Group may have a position in and may make a purchase and / or sale of any of the securities or other financial instruments mentioned in this document.

      UBS funds under Luxembourg and Irish law

        Before investing in a product please read the latest prospectus carefully and thoroughly. Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. Commissions and costs have a negative impact on performance. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS AG. Source for all data and charts (if not indicated otherwise): UBS Asset Management

          This document contains statements that constitute “forward-looking statements”, including, but not limited to, statements relating to our future business development. While these forward-looking statements represent our judgments and future expectations concerning the development of our business, a number of risks, uncertainties and other important factors could cause actual developments and results to differ materially from our expectations.

            Prospectuses, simplified prospectuses or key investor information, the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available in a language required by the local applicable law free of charge from UBS Asset Management, Regeringsgatan 38, S-11153 Stockholm.

              © UBS 2022. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.

              Back

              UBS ETF (LU) Solactive China Technology UCITS ETF (hedged to EUR) A-acc

              Net asset value 6.4999EUR

              Last update

              27.06.2022

              ISIN: LU2265794946

              Asset Class: Equities

              Download all data as XLS File

              10 largest constituents

              #

              Securities

              ISIN

              Currency

              Price

              Weight %

              1

              MEITUAN-CLASS B

              KYG596691041

              HKD

              198.10

              11.24

              2

              ALIBABA GROUP HOLDING-SP ADR

              US01609W1027

              USD

              117.62

              10.09

              3

              TENCENT HOLDINGS LTD

              KYG875721634

              HKD

              384.20

              9.34

              4

              PINDUODUO INC-ADR

              US7223041028

              USD

              65.96

              7.86

              5

              BAIDU INC - SPON ADR

              US0567521085

              USD

              151.34

              5.51

              6

              NETEASE INC ADR USD 0.0001

              US64110W1027

              USD

              93.60

              5.09

              7

              BYD CO LTD-H

              CNE100000296

              HKD

              310.20

              4.83

              8

              WUXI BIOLOGICS CAYMAN INC

              KYG970081173

              HKD

              77.20

              4.57

              9

              NIO INC - ADR

              US62914V1061

              USD

              24.08

              4.39

              10

              XIAOMI CORP-CLASS B

              KYG9830T1067

              HKD

              12.22

              3.03

              This overview shows the portfolio positions. The actual positions of the ETF may deviate from this. Source: State Street, 24.06.2022

              Composition data

              Ticker

              CITE IM

              Total net assets

              8,253,223.26

              Total outstanding ETF Shares

              1,277,178.00

              Base currency

              EUR

              Source: State Street, 27.06.2022

              Disclaimer

              For marketing and information purposes by UBS. UBS funds under Luxembourg law. Arrangements for marketing fund units mentioned in this document may be terminated at the initiative of the management company of the fund(s). Prospectuses, key investor information (KIID), the articles of association or the management regulations as well as annual and semi-annual reports of UBS funds are available in a language required by the local applicable law free of charge from UBS Asset Management, Regeringsgatan 38, S-11153 Stockholm and online at www.ubs.com/etf. The product described herein aligns to Article 6 of Regulation (EU) 2019/2088 on sustainability-related disclosures in the financial services sector. Information on sustainability-related aspects pursuant to that regulation can be found on www.ubs.com/funds. The benchmark is the intellectual property of the respective index provider. The fund or the share class is neither sponsored nor endorsed by the index provider. The fund prospectus or supplemental prospectus contains the full disclaimer. Before investing in a product please read the latest prospectus and key investor information document carefully and thoroughly. Any decision to invest should take into account all the characteristics or objectives of the fund as described in its prospectus, or similar legal documentation. Investors are acquiring units or shares in a fund, and not in a given underlying asset such as building or shares of a company. The information and opinions contained in this document have been compiled or arrived at based upon information obtained from sources believed to be reliable and in good faith, but is not guaranteed as being accurate, nor is it a complete statement or summary of the securities, markets or developments referred to in the document. Members of the UBS Group may have a position in and may make a purchase and / or sale of any of the securities or other financial instruments mentioned in this document. Units of UBS funds mentioned herein may not be eligible for sale in all jurisdictions or to certain categories of investors and may not be offered, sold or delivered in the United States. The information mentioned herein is not intended to be construed as a solicitation or an offer to buy or sell any securities or related financial instruments. Past performance is not a reliable indicator of future results. The performance shown does not take account of any commissions and costs charged when subscribing to and redeeming units. If whole or part of the total costs to be paid is different from your reference currency, the costs may increase or decrease as a result of currency and exchange rate fluctuations. Commissions and costs have a negative impact on the investment and on the expected returns. If the currency of a financial product or financial service is different from your reference currency, the return can increase or decrease as a result of currency and exchange rate fluctuations. This information pays no regard to the specific or future investment objectives, financial or tax situation or particular needs of any specific recipient. Future performance is subject to taxation which depends on the personal situation of each investor and which may change in the future. The details and opinions contained in this document are provided by UBS without any guarantee or warranty and are for the recipient's personal use and information purposes only. This document may not be reproduced, redistributed or republished for any purpose without the written permission of UBS Asset Management Switzerland AG or a local affiliated company. Source for all data and charts (if not indicated otherwise): UBS Asset Management. A summary of investor rights in English can be found online at www.ubs.com/funds. More explanations of financial terms can be found at www.ubs.com/am-glossary.
              © UBS 2022. The key symbol and UBS are among the registered and unregistered trademarks of UBS. All rights reserved.